Time to Viral Load Suppression and Its Predictors Among Adult Patients on Antiretro Viral Therapy in Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital, Hossana, Southern Ethiopia

References

• Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984;224(4648):500–503. doi:10.1126/science.6200936
   PubMed Web of Science ®Google Scholar
• UNAIDS. 90-90-90 an Ambitious Treatment Target to Help End the AIDS Epidemic. Geneva, Switzerland: UNAIDS; 2017.
   Google Scholar
• Ministry of Health E. National Consolidated Guidelines for Comprehensive HIV Prevention, Care and Treatment. Addis Ababa: MoH; 2018.
   Google Scholar
• UNAIDS. Fact sheet - global HIV statistics; 2021. Available from: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. Accessed April 17, 2023.
   Google Scholar
• UNAIDS. UNAIDS DATA 2017. UNAIDS; 2017. Available from: https://www.unaids.org/sites/default/files/media_asset/20170720_Data_book_2017_en.pdf. Accessed April 17, 2023.
   Google Scholar
• Stephen D, Anthony D, Xavier A, Landon M, Robin W. Early mortality among adults accessing antiretroviral treatment program in sub-Saharan Africa. NIH AIDS. 2008;22:15.
   PubMed Web of Science ®Google Scholar
• Pyngottu A, Scherrer AU, Kouyos R. Predictors of virological failure and time to viral suppression of first-line integrase inhibitor–based antiretroviral treatment. Clin Infect Dis. 2021;73(7):e2134–e2141. doi:10.1093/cid/ciaa1614
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Geneva, Switzerland: World Health Organization; 2013.
   Google Scholar
• World Health Organization. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva, Switzerland: World Health Organization Press; 2015.
   Google Scholar
• Chakraborty H, Iyer M, Duffus WA, Samantapudi AV, Albrecht H, Weissman S. Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina. AIDS Patient Care STDS. 2015;29(1):26–32. doi:10.1089/apc.2014.0158
   PubMed Web of Science ®Google Scholar
• Maina E, Mureithi H, Adan A, Muriuki J, Lwembe R, Bukusi E. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya. Int J Infect Dis. 2020;97:151–158. doi:10.1016/j.ibid.2020.05.097
   PubMed Web of Science ®Google Scholar
• WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. In: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2014.
   Google Scholar
• Mayo Clinic. Definition of HIV; 2015. Available from: http://www.mayoclinic.org/diseasesconditions/HIV-AIDS/basics/definition/con-20013732. Accessed April 17, 2023.
   Google Scholar
• A collaboration of UNAIDS UaW. Global factsheets AIDSinfo; 2021. Available from: https://aidsinfo.unaids.org/. Accessed April 17, 2023.
   Google Scholar
• Levi J, Alice R, Anton P, Pietro V, Philipp K, Andrew H. Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Glob Health. 2016;1(2):e000010. doi:10.1136/bmjgh-2015-000010
   PubMed Web of Science ®Google Scholar
• UNAIDS. Country factsheets Ethiopia AIDSinfo; 2020. Available from: https://aidsinfo.unaids.org/. Accessed April 17, 2023.
   Google Scholar
• UNAIDS. An ambitious treatment target to help end the AIDS epidemic. 2014.
   Google Scholar
• UNAIDS. Global AIDS update; 2021. Available from: https://aidsinfo.unaids.org/. Accessed April 17, 2023.
   Google Scholar
• Palmer A, Gabler K, Rachlis B, et al. Viral suppression and viral rebound among young adults living with HIV in Canada. Medicine. 2018;97(22):e10562. doi:10.1097/MD.0000000000010562
   PubMed Web of Science ®Google Scholar
• Hussein S, Mama M, Mekonnen B, et al. Predictors of time to viral load suppression of adult PLWHIV on ART in Arba Minch General Hospital: a follow-up study. Ethiop J Health Sci. 2019;29(6):751–758. doi:10.4314/ejhs.v29i6.12
   PubMed Web of Science ®Google Scholar
• Ali JH, Yirtaw TG. Time to viral load suppression and its associated factors in a cohort of patients taking antiretroviral treatment in East Shewa zone, Oromiya, Ethiopia, 2018. BMC Infect Dis. 2019;19:1084. doi:10.1186/s12879-019-4702-z
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. C6. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf. Accessed March 22, 2022.
   Google Scholar
• Ethiopia MoHo. National Guidelines for Comprehensive HIV Prevention Care and Treatment, 2019. Addis Ababa, Ethiopia: Ethiopia MoHo; 2019.
   Google Scholar
• Atnafu GT, Moges NA, Wubie M, Gedif G. Incidence and predictors of viral load suppression after enhanced adherence counseling among HIV-positive adults in West Gojjam Zone, Amhara Region, Ethiopia. Infect Drug Resist. 2022;15:261–274. doi:10.2147/IDR.S341392
   PubMed Web of Science ®Google Scholar
• Desta AA, Woldearegay TW, Futwi N, et al. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis. 2020;20(1):4. doi:10.1186/s12879-019-4732-6
   PubMed Web of Science ®Google Scholar
• Ssemwanga D, Asio J, Waters C, et al. Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda. J Antimicrob Chemother. 2020;75:1280–1289. doi:10.1093/jac/dkz561
   PubMed Web of Science ®Google Scholar
• Steegen K, Bronze M, Papathanasopoulos MA, et al. HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. J Antimicrob Chemother. 2017;72:210–219. doi:10.1093/jac/dkw358
   PubMed Web of Science ®Google Scholar